Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$953M |
| 2 |
NVIDIA
NVDA
|
+$784M |
| 3 |
Meta Platforms (Facebook)
META
|
+$753M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$316M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$315M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.17B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$506M |
| 4 |
Abbott
ABT
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$325M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Healthcare | 16.94% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Consumer Staples | 9.16% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Kelly Services Class A
KELYA
$486M
| $1.17M | ﹤0.01% |
+66,508
| New | +$1.17M |
|
|
LAND
2377
Gladstone Land Corp
LAND
$321M
| $1.17M | ﹤0.01% |
71,900
-28,000
| -28% | -$456K |
|
|
CTHR
2378
DELISTED
Charles & Colvard Ltd
CTHR
| $1.17M | ﹤0.01% |
122,121
-10,096
| -8% | -$96.4K |
|
2379
Tronox
TROX
$783M
| $1.16M | ﹤0.01% |
91,600
-239,500
| -72% | -$3.04M |
|
2380
AMES National
ATLO
$183M
| $1.16M | ﹤0.01% |
64,384
-2,600
| -4% | -$46.9K |
|
2381
Sensus Healthcare
SRTS
$51.8M
| $1.16M | ﹤0.01% |
367,934
+91,800
| +33% | +$289K |
|
|
SUPV
2382
Grupo Supervielle
SUPV
$469M
| $1.16M | ﹤0.01% |
372,069
-11,811
| -3% | -$36.7K |
|
2383
First Community Corp
FCCO
$216M
| $1.16M | ﹤0.01% |
66,569
+1,400
| +2% | +$24.3K |
|
|
GPMT
2384
Granite Point Mortgage Trust
GPMT
$140M
| $1.15M | ﹤0.01% |
217,700
+186,502
| +598% | +$989K |
|
2385
Stellar Bancorp
STEL
$1.59B
| $1.15M | ﹤0.01% |
50,396
+2,200
| +5% | +$50.4K |
|
2386
IBEX
IBEX
$520M
| $1.15M | ﹤0.01% |
54,016
+28,216
| +109% | +$599K |
|
|
UBP
2387
DELISTED
Urstadt Biddle Properties Inc.
UBP
| $1.15M | ﹤0.01% |
54,400
+5,100
| +10% | +$107K |
|
|
TCFC
2388
DELISTED
The Community Financial Corporation Common Stock
TCFC
| $1.15M | ﹤0.01% |
42,268
-4,770
| -10% | -$129K |
|
2389
Matrix Service
MTRX
$365M
| $1.14M | ﹤0.01% |
194,044
-44,306
| -19% | -$261K |
|
2390
Fulcrum Therapeutics
FULC
$382M
| $1.14M | ﹤0.01% |
344,810
-45,290
| -12% | -$149K |
|
|
ATYR
2391
aTyr Pharma
ATYR
$106M
| $1.14M | ﹤0.01% |
526,355
+368,700
| +234% | +$796K |
|
|
SCWX
2392
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $1.14M | ﹤0.01% |
157,140
+82,000
| +109% | +$593K |
|
2393
Talkspace
TALK
$429M
| $1.13M | ﹤0.01% |
891,715
+465,259
| +109% | +$591K |
|
2394
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$3.81B
| $1.13M | ﹤0.01% |
44,200
-227,200
| -84% | -$5.81M |
|
2395
Cartesian Therapeutics
RNAC
$255M
| $1.12M | ﹤0.01% |
33,417
-2,353
| -7% | -$79.1K |
|
2396
Riverview Bancorp
RVSB
$102M
| $1.12M | ﹤0.01% |
222,804
-24,603
| -10% | -$124K |
|
2397
Semler Scientific
SMLR
$420M
| $1.12M | ﹤0.01% |
42,800
+20,500
| +92% | +$538K |
|
|
NWLI
2398
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.12M | ﹤0.01% |
2,700
+600
| +29% | +$249K |
|
2399
Corvus Pharmaceuticals
CRVS
$438M
| $1.12M | ﹤0.01% |
489,673
-16,359
| -3% | -$37.5K |
|
2400
CS Disco
LAW
$370M
| $1.12M | ﹤0.01% |
136,400
-95,700
| -41% | -$787K |
|